

Specialty Infusion
Patagonia partners with provider organizations to assess potential, design, operationalize, scale and optimize specialty infusion services
Background
For decades, infusion services have been primarily driven by oncology, where complex intravenous therapies have formed the foundation of cancer treatment delivery.
In recent years, however, the specialty infusion therapeutics landscape has evolved significantly. Advances in biomedical research and diagnostic science have enabled the identification of hundreds of new rare diseases each year, nearly doubling the number of known rare diseases over the past five years.
This rapid expansion in disease recognition has, in turn, fueled therapeutic innovation. An exponentially growing number of specialty therapeutics now populate the development pipeline, with many therapies already in late-stage development or FDA-approved, addressing newly identified conditions while expanding treatment options for established diseases. Collectively, these advances have transformed our ability to diagnose, manage, and control complex conditions, altering disease trajectories and levels of control in ways previously unattainable.
As therapeutic options continue to expand, specialty infusion infrastructure becomes increasingly vital to effective care delivery. Yet specialty infusion services face multiple layers of internal and external complexity. Significant barriers to entry, escalating clinical and operational demands, and evolving care requirements make intentional infusion design imperative, not only to support high-quality care delivery, but also to drive operational efficiency and ensure the viability and sustainability of specialty infusion services.
Patagonia Healthcare partners with provider organizations to leverage this therapeutic innovation to help meet the increasing patient care demand through validated, scalable specialty infusion strategies. Our integrated approach spans the full lifecycle of program development, from assessing addressable opportunity and developing center-specific pro formas, to program design, implementation, real-time operational support, clinical service development, and proven scalability strategies. Patagonia Healthcare is your partner in creating, scaling, and optimizing specialty infusion services, diversifying your service and revenue mix, while positioning you as the patient destination of choice for access to the most innovative specialty therapeutics.
Outcomes
Infusion Access to Hospital Managed Care Contracts
Access to 340B Pricing
Build Within Existing Real-Estate Infrastructure
Sites Achieving Break Even Within Six Months of Launch
Compliance With Drug Protocol Development
100%
Centralization of Intake, Authorization, Scheduling and Patient Financial Services
<1%
Drug Referral Bounce Back
Fatal Drug Denial Rate
>90% Drug Authorization Success in HOPD Setting
70% Net New Revenue
60% Net New Patients
Open Drug Formulary Strategy
Validated HOPD Models Operating for 5 Years
Hospital Length of Stay Optimization
Reduction of Hospital Acute Drug Budget
Diversification of Service Mix
Diversification of Revenue Streams
Largest Market Share Capture of Rare Disease Specialty Infusions
Services

Request a Strategy Consult

Your Partner
For All Things
Specialty Infusion

